Search results
Results from the WOW.Com Content Network
Collectively, pundits tracking Quest's stock were modeling $2.58 billion on the top line. They also underestimated profitability, with an average projection of $2.19 per share for adjusted net income.
Quest Diagnostics (DGX) closed the most recent trading day at $118.40, moving -0.08% from the previous trading session. This move was narrower than the S&P 500's daily loss of 0.22%.
Let's see if Quest Diagnostics (DGX) stock is a good choice for value-oriented investors right now from multiple angles.
Looking ahead to 2025, Quest Diagnostics projects revenue in the range of $10.70 billion to $10.85 billion, indicating continuous growth. The adjusted diluted EPS guidance stands between $9.55 and ...
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States , Puerto Rico , Mexico , and Brazil . [ 3 ] Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
For premium support please call: 800-290-4726 more ways to reach us
Stock name Symbol Country of origin Q2 Holdings, Inc. QTWO: US Qiagen N.V. QGEN: Netherlands: Quad/Graphics, Inc. QUAD: US Quaker Chemical Corporation: KWR: US Quanex Building Products Corporation NX: US Quanta Services Inc. PWR: US Quantum FinTech Acquisition Corporation QFTA: US Quantum FinTech Acquisition Corporation QFTA.UN: US QuantumScape ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.